针对老年人的疫苗：对理想动物模型的探索。
Vaccines for the elderly: the quest for the ideal animal model.
作者信息
Boudet F
机构信息
Sanofi-Pasteur, Research Department, Marcy L'Etoile, France.
出版信息
J Comp Pathol. 2010 Jan;142 Suppl 1:S70-3. doi: 10.1016/j.jcpa.2009.10.005. Epub 2009 Nov 7.
Abstract
A decline in protective immune responses following vaccination is one of the main features of immunosenescence. Improved vaccine candidates for elderly adults are thus urgently needed. For scientific and regulatory requirements, such new vaccines must first be evaluated at the preclinical level, and there is a continuing quest for the ideal animal model with which to perform such studies. The main advantages and limitations of murine models, those most commonly used for human vaccine research, and of large animal models are reviewed and discussed.
摘要
疫苗接种后保护性免疫反应的下降是免疫衰老的主要特征之一。因此，迫切需要为老年人研发更好的候选疫苗。出于科学和监管要求，此类新疫苗必须首先在临床前水平进行评估，并且一直在寻找用于开展此类研究的理想动物模型。本文综述并讨论了最常用于人类疫苗研究的小鼠模型和大型动物模型的主要优缺点。
相似文献
1
Vaccines for the elderly: the quest for the ideal animal model.针对老年人的疫苗：对理想动物模型的探索。
J Comp Pathol. 2010 Jan;142 Suppl 1:S70-3. doi: 10.1016/j.jcpa.2009.10.005. Epub 2009 Nov 7.
2
Biology of immune responses to vaccines in elderly persons.老年人对疫苗免疫反应的生物学机制。
Clin Infect Dis. 2008 Apr 1;46(7):1078-84. doi: 10.1086/529197.
3
Targeting Inflammation and Immunosenescence to Improve Vaccine Responses in the Elderly.针对炎症和免疫衰老改善老年人的疫苗应答。
Front Immunol. 2020 Oct 14;11:583019. doi: 10.3389/fimmu.2020.583019. eCollection 2020.
4
Immunosenescence and vaccine failure in the elderly: strategies for improving response.老年人的免疫衰老与疫苗接种失败：改善免疫反应的策略
Immunol Lett. 2014 Nov;162(1 Pt B):346-53. doi: 10.1016/j.imlet.2014.06.006. Epub 2014 Jun 21.
5
Understanding immunosenescence to improve responses to vaccines.了解免疫衰老以提高疫苗反应。
Nat Immunol. 2013 May;14(5):428-36. doi: 10.1038/ni.2588. Epub 2013 Apr 18.
6
Effect of ageing on the immune response of dogs to vaccines.衰老对犬类疫苗免疫反应的影响。
J Comp Pathol. 2010 Jan;142 Suppl 1:S74-7. doi: 10.1016/j.jcpa.2009.09.006. Epub 2009 Nov 7.
7
Vaccine responsiveness in the elderly: best practice for the clinic.老年人的疫苗反应性：临床最佳实践
Expert Rev Vaccines. 2014 Jul;13(7):885-94. doi: 10.1586/14760584.2014.924403. Epub 2014 Jun 3.
8
A systems biology approach to the effect of aging, immunosenescence and vaccine response.一种关于衰老、免疫衰老和疫苗反应影响的系统生物学方法。
Curr Opin Immunol. 2014 Aug;29:62-8. doi: 10.1016/j.coi.2014.04.005. Epub 2014 May 13.
9
Vaccination in the elderly: an immunological perspective.老年人的疫苗接种：免疫学视角
Trends Immunol. 2009 Jul;30(7):351-9. doi: 10.1016/j.it.2009.05.002. Epub 2009 Jun 18.
10
Problems and solutions to the development of vaccines in the elderly.老年人疫苗研发中的问题与解决方案。
Immunol Allergy Clin North Am. 2003 Feb;23(1):41-55. doi: 10.1016/s0889-8561(02)00055-3.
引用本文的文献
1
Prime-pull vaccination with a plant-derived virus-like particle influenza vaccine elicits a broad immune response and protects aged mice from death and frailty after challenge.用植物源病毒样颗粒流感疫苗进行初免-加强免疫接种可引发广泛的免疫反应，并保护老年小鼠在受到攻击后免于死亡和虚弱。
Immun Ageing. 2019 Nov 4;16:27. doi: 10.1186/s12979-019-0167-6. eCollection 2019.
2
3
Immunological hurdles of ageing: indispensable research of the human model.免疫衰老的障碍：人类模型不可或缺的研究。
Ageing Res Rev. 2011 Jul;10(3):315-8. doi: 10.1016/j.arr.2011.01.005. Epub 2011 Feb 21.
本文引用的文献
1
Development of effective vaccines for old mice in a tumor model.在肿瘤模型中为老年小鼠研发有效疫苗。
Vaccine. 2009 Feb 11;27(7):1093-100. doi: 10.1016/j.vaccine.2008.11.112. Epub 2008 Dec 25.
2
Intradermal influenza vaccine administered using a new microinjection system produces superior immunogenicity in elderly adults: a randomized controlled trial.使用新型微量注射系统接种的皮内流感疫苗在老年人中产生了更高的免疫原性：一项随机对照试验。
J Infect Dis. 2008 Sep 1;198(5):650-8. doi: 10.1086/590434.
3
The effect of age on serum antibody titers after rabies and influenza vaccination in healthy horses.年龄对健康马匹接种狂犬病和流感疫苗后血清抗体滴度的影响。
J Vet Intern Med. 2008 May-Jun;22(3):654-61. doi: 10.1111/j.1939-1676.2008.0091.x. Epub 2008 May 2.
4
Age-related decline in immunity: implications for vaccine responsiveness.与年龄相关的免疫功能衰退：对疫苗反应性的影响。
Expert Rev Vaccines. 2008 May;7(4):467-79. doi: 10.1586/14760584.7.4.467.
5
Use of animal models in the development of human vaccines.动物模型在人类疫苗研发中的应用。
Future Microbiol. 2007 Dec;2(6):667-75. doi: 10.2217/17460913.2.6.667.
6
Advances in pneumococcal vaccines: what are the advantages for the elderly?肺炎球菌疫苗的进展：对老年人有哪些益处？
Drugs Aging. 2007;24(10):791-800. doi: 10.2165/00002512-200724100-00001.
7
Old rhesus macaques treated with interleukin-7 show increased TREC levels and respond well to influenza vaccination.用白细胞介素-7治疗的老年恒河猴显示TREC水平升高，并且对流感疫苗接种反应良好。
Rejuvenation Res. 2007 Mar;10(1):5-17. doi: 10.1089/rej.2006.9098.
8
Age-related changes in immunity: implications for vaccination in the elderly.免疫方面与年龄相关的变化：对老年人疫苗接种的影响。
Expert Rev Mol Med. 2007 Feb 1;9(3):1-17. doi: 10.1017/S1462399407000221.
9
Utility of the aged BALB/c mouse model to demonstrate prevention and control strategies for severe acute respiratory syndrome coronavirus (SARS-CoV).老年BALB/c小鼠模型在展示严重急性呼吸综合征冠状病毒（SARS-CoV）防控策略方面的效用。
Vaccine. 2007 Mar 8;25(12):2173-9. doi: 10.1016/j.vaccine.2006.11.055. Epub 2006 Dec 11.
10
Is there an ideal animal model for SARS?是否存在用于非典的理想动物模型？
Trends Microbiol. 2006 Jul;14(7):299-303. doi: 10.1016/j.tim.2006.05.007. Epub 2006 Jun 8.
Zotero 插件